Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bromocriptine in depression

N Bouras, P K Bridges

    Current Medical Research and Opinion
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    This study compared bromocriptine and imipramine for treating depression. Both drugs showed similar effectiveness in reducing depression symptoms over 10 weeks, with fewer side effects for bromocriptine.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Computed-tomography angiography in arterial acute intestinal ischemia: prognostic interest of vascular semiology.

    Abdominal radiology (New York)·2021
    Same author

    COVID-19 enabled co-authoring networks: a country-case analysis.

    Scientometrics·2021
    Same author

    A new dithiolopyrrolone antibiotic triggered by a long fermentation of Saccharothrix algeriensis NRRL B-24137 in sorbic acid-amended medium.

    Letters in applied microbiology·2019
    Same author

    Effective biosynthesis of benzoyl-pyrrothine dithiolopyrrolone antibiotic by cinnamic acid-precursor addition in culture of Saccharothrix algeriensis NRRL B-24137.

    Letters in applied microbiology·2018
    Same author

    Oligomycins A and E, major bioactive secondary metabolites produced by Streptomyces sp. strain HG29 isolated from a Saharan soil.

    Journal de mycologie medicale·2017
    Same author

    Social challenges of contemporary psychiatry.

    Psychiatrike = Psychiatriki·2017
    Same journal

    Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

    Current medical research and opinion·2026
    Same journal

    RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

    Current medical research and opinion·2026
    Same journal

    Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

    Current medical research and opinion·2026
    Same journal

    Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

    Current medical research and opinion·2026
    Same journal

    BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

    Current medical research and opinion·2026
    Same journal

    Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

    Current medical research and opinion·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Clinical Pharmacology

    Background:

    • Endogenous depression is a significant mood disorder.
    • Pharmacological interventions are crucial for managing depression.
    • Bromocriptine and imipramine are established treatments for depression.

    Purpose of the Study:

    • To compare the efficacy and side effect profiles of bromocriptine and imipramine in treating endogenous depression.
    • To evaluate the effectiveness of bromocriptine as an alternative antidepressant medication.

    Main Methods:

    • A double-blind, randomized trial involving 9 patients with endogenous depression.
    • Treatment groups: bromocriptine (15 mg/day) and imipramine (75 mg/day) for 10 weeks.
    • Assessment of depression severity using the Hamilton Rating Scale for Depression (HAM-D).

    Related Experiment Videos

    Main Results:

    • Both bromocriptine and imipramine demonstrated comparable reductions in mean HAM-D scores.
    • No statistically significant difference in antidepressant efficacy was observed between the two treatment groups.
    • Bromocriptine was associated with fewer anticholinergic side effects compared to imipramine, though transient nausea occurred in some patients.

    Conclusions:

    • Bromocriptine is an effective treatment for endogenous depression, comparable to imipramine.
    • Bromocriptine may offer a favorable side effect profile, particularly regarding anticholinergic effects.
    • Further research with larger sample sizes is warranted to confirm these findings.